Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 912Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 13Canalia

02 17Tenelia

PharmaCompass

01

Brand Name : Tenelia

Teneligliptin

arrow
DIA 2025
Not Confirmed

02

Brand Name : Canalia

Teneligliptin

arrow
APS Symposium
Not Confirmed

Brand Name : Canalia

arrow
APS Symposium
Not Confirmed

Teneligliptin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 137

2019 Revenue in Millions : 112

Growth (%) : 22

blank

03

Brand Name : Tenelia

Teneligliptin

arrow
APS Symposium
Not Confirmed

04

Brand Name : Canalia

Teneligliptin

arrow
APS Symposium
Not Confirmed

Brand Name : Canalia

arrow
APS Symposium
Not Confirmed

Teneligliptin

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 139

2020 Revenue in Millions : 136

Growth (%) : 11

blank

05

Brand Name : Tenelia

Teneligliptin

arrow
APS Symposium
Not Confirmed

Brand Name : Tenelia

arrow
APS Symposium
Not Confirmed

Teneligliptin

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 200

2020 Revenue in Millions : 220

Growth (%) : -2

blank

06

Brand Name : Canalia

Teneligliptin

arrow
APS Symposium
Not Confirmed

07

Brand Name : Tenelia

Teneligliptin

arrow
APS Symposium
Not Confirmed

08

Brand Name : Canalia

Teneligliptin

arrow
APS Symposium
Not Confirmed

09

Brand Name : Canalia

Teneligliptin

arrow
APS Symposium
Not Confirmed

10

Brand Name : Tenelia

Teneligliptin

arrow
APS Symposium
Not Confirmed

Brand Name : Tenelia

arrow
APS Symposium
Not Confirmed

Teneligliptin

Main Therapeutic Indication : Diabetes

Currency : USD

2022 Revenue in Millions : 170

2021 Revenue in Millions : 200

Growth (%) : -15

blank